CL vs ORMP
Colgate-Palmolive Company (CL) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the CL and ORMP stock pages for the full models.
Not investment advice.